[Bayés Syndrome, Stroke and Dementia]

Area of Science:

• Cardiology
• Electrophysiology
• Neurology

Context:

• Bayés's syndrome links advanced interatrial block (A-IAB) with supraventricular tachyarrhythmias, primarily atrial fibrillation (AF).
• This syndrome is associated with increased risks of thromboembolic events, including stroke, cognitive impairment, and dementia.

Purpose:

• To investigate the efficacy of early anticoagulation therapy in patients with A-IAB before documented AF.
• To determine if anticoagulation can prevent thromboembolic events in this high-risk population.

Summary:

• Studies are evaluating anticoagulation's role in patients with A-IAB, even without prior AF diagnosis.
• Ongoing trials aim to establish whether preemptive anticoagulation prevents stroke and cognitive decline in Bayés's syndrome.

Impact:

• Findings will clarify the therapeutic role of anticoagulation in A-IAB management.
• This research could lead to new guidelines for preventing stroke and dementia in Bayés's syndrome patients.